I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
- Written by PR Newswire
![]() |
ROCKVILLE, Md., Nov. 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean (Xi-Yong) Fu, PhD, MBA has been appointed as the Company's permanent Chief Executive...
Read more: I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer















